DRUG DELIVERY COMPOSITION USING CROSSLINKED HYALURONIC ACID AND MANUFACTURING METHOD THEREFOR

Title:

DRUG DELIVERY COMPOSITION USING CROSSLINKED HYALURONIC ACID AND MANUFACTURING METHOD THEREFOR

Document Type and Number:

WIPO Patent Application WO/2021/172694

Kind Code:

A1

Abstract:

The present invention relates to a drug delivery composition using crosslinked hyaluronic acid, a manufacturing method therefor, and a pharmaceutical composition comprising the drug delivery composition and a drug and having a desired release behavior.

More Like This:

JP2005008596	OPHTHALMOLOGICAL COMPOSITION
JP2017537944	Mouth refresher
JP2002504508	INDUSTRIAL APPLICABILITY: Cross-linked hyperamylose starch having a functional group as a sustained-release matrix of a drug.

Inventors:

LEE YUNGEE (KR)
CHOI MINYONG (KR)
HAN SONGYI (KR)
LEE MYEONG HEE (KR)

Application Number:

PCT/KR2020/014829

Publication Date:

September 02, 2021

Filing Date:

October 28, 2020

Export Citation:

Click for automatic bibliography generation Help

Assignee:

JP CARES (KR)

International Classes:

A61K47/36; A61K9/06; A61K31/445; A61P23/02

Foreign References:

KR20160100265A	2016-08-23
KR20160027095A	2016-03-09
KR20190103559A	2019-09-05

Other References:

JIANYU LI, DAVID J. MOONEY: "Designing hydrogels for controlled drug delivery", NATURE REVIEWS MATERIALS, vol. 1, no. 12, pages 16071, XP055462134, DOI: 10.1038/natrevmats.2016.71
See also references of EP 4112082A4

Attorney, Agent or Firm:

YOU ME PATENT AND LAW FIRM (KR)

Download PDF:

View/Download PDF PDF Help

Previous Patent: ELECTRONIC DEVICE INCLUDING TRANSMISSION STRUCTURE FOR NON-CONTACT WIRELESS POWER TRANSMISSION AND N...

Next Patent: METHOD FOR PROVIDING INFORMATION FOR PREDICTING PATHOLOGICAL STAGE OF LUNG CANCER, AND DEVICE FOR PR...